News Release
7.10.2025
Merz Therapeutics Expands Presence with New Affiliate in...
Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the opening of its new affiliate in Warsaw, Poland....
Read more
Global
Every announcement we make appears here first. You can also search for older announcements. If you need information that’s not here, please contact us.
News Release
7.10.2025
Merz Therapeutics Expands Presence with New Affiliate in...
Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the opening of its new affiliate in Warsaw, Poland....
Read more
News Release
25.08.2025
Merz Therapeutics Announces First Patients Enrolled in Two...
Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients have been enrolled in two...
Read more
News Release
24.06.2025
Teijin Receives Approval for Additional Indication for...
Teijin Pharma Limited and Merz Therapeutics GmbH jointly announced today that Teijin Pharma has received approval from Japan’s Ministry of Health.
Read more
News Release
30.01.2025
Merz Therapeutics Launches FAMPYRA® in Canada, EMEA, LATAM...
As part of its strategic vision to become a leader in the specialty neurology space, Merz Therapeutics has launched FAMPYRA®...
Read more
News Release
21.01.2025
Karen LaRochelle Joins Merz Therapeutics as Global Head of...
Merz Therapeutics is pleased to announce the appointment of Karen LaRochelle as the new Global Head of Business Strategy and Portfolio Innovation.
Read more
News Release
17.12.2024
Health Canada Approves XEOMIN® (incobotulinumtoxinA) for...
Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, today announced that Health Canada approved...
Read more
Merz Therapeutics GmbH
Luke Mircea-Willats
Global Communications
luke.mirceawillats@merz.ch
We’ve put a range of media-supporting materials, including photography and logos, into one place for ease of use.
You are leaving this website. With respect to the content of the following page, as well as to links to other websites located on this page, Merz Therapeutics GmbH has no way of controlling the content of these sites. Merz Therapeutics GmbH assumes no responsibility for the content of these sites or the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.
You are leaving this website. The content of the following sites maintained by the parent company or another affiliated company, or links to other sites located on this site, is subject to the legal requirements of the country in which the site is maintained. Merz Therapeutics GmbH accepts no responsibility whatsoever for the content of these websites or for the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.